In a head to head trial, oral semaglutide was non-inferior to another injectable GLP-1 for blood sugar, which shows the pill is a real option, not a watered down one (the PIONEER 4 randomized trial comparing oral semaglutide with an injectable GLP-1)
Similarly, Eric Polley, PhD, a UChicago data science and public health expert, recently led a study published in Nature Cardiovascular Research that used statistical modeling to emulate a clinical trial comparing the effects of four different classes of diabetes medication in patients with moderate cardiovascular risk
Clinical studies, as well as our own patient experiences, show that the most meaningful results are often seen between 3 to 6 months, as weight loss progresses gradually over time
When taking medications, its essential to know how they might interact with each other